Global In Vitro Diagnostics Market to Reach $134.3 Billion by 2030
The global market for In Vitro Diagnostics estimated at US$103 Billion in the year 2022, is projected to reach a revised size of US$134.3 Billion by 2030, growing at a CAGR of 3.4% over the analysis period 2022-2030. Reagents & Kits, one of the segments analyzed in the report, is projected to record 3.2% CAGR and reach US$86.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Instruments segment is readjusted to a revised 3.9% CAGR for the next 8-year period.The U.S. Market is Estimated at $27.6 Billion, While China is Forecast to Grow at 5.1% CAGR
The In Vitro Diagnostics market in the U.S. is estimated at US$27.6 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$27.1 Billion by the year 2030 trailing a CAGR of 5.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.2% and 2.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.6% CAGR.Select Competitors (Total 58 Featured) -
- Abbott Laboratories
- Agilent Technologies, Inc.
- Becton, Dickinson & Company
- bioMerieux SA
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- DiaSorin SpA
- Johnson & Johnson
- Ortho Clinical Diagnostics
- Qiagen NV
- Roche Diagnostics (Schweiz) AG
- Siemens AG
- Sysmex Corporation
- Thermo Fisher Scientific, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Agilent Technologies, Inc.
- Becton, Dickinson & Company
- bioMerieux SA
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- DiaSorin SpA
- Johnson & Johnson
- Ortho Clinical Diagnostics
- Qiagen NV
- Roche Diagnostics (Schweiz) AG
- Siemens AG
- Sysmex Corporation
- Thermo Fisher Scientific, Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 181 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 103 Billion |
Forecasted Market Value ( USD | $ 134.3 Billion |
Compound Annual Growth Rate | 3.4% |
Regions Covered | Global |